Medical University of Vienna, Center for Physiology and Pharmacology, Schwarzspanierstr. 17, A-1090 Vienna, Austria.
Biochem Soc Trans. 2013 Feb 1;41(1):197-204. doi: 10.1042/BST20120256.
The design and development of selective ligands for the human OT (oxytocin) and AVP (arginine vasopressin) receptors is a big challenge since the different receptor subtypes and their native peptide ligands display great similarity. Detailed understanding of the mechanism of OT's interaction with its receptor is important and may assist in the ligand- or structure-based design of selective and potent ligands. In the present article, we compared 69 OT- and OT-like receptor sequences with regards to their molecular evolution and diversity, utilized an in silico approach to map the common ligand interaction sites of recently published G-protein-coupled receptor structures to a model of the human OTR (OT receptor) and compared these interacting residues within a selection of different OTR sequences. Our analysis suggests the existence of a binding site for OT peptides within the common transmembrane core region of the receptor, but it appears extremely difficult to identify receptor or ligand residues that could explain the selectivity of OT to its receptors. We remain confident that the presented evolutionary overview and modelling approach will aid interpretation of forthcoming OTR crystal structures.
设计和开发选择性配体用于人类 OT(催产素)和 AVP(精氨酸加压素)受体是一个巨大的挑战,因为不同的受体亚型及其天然肽配体显示出很大的相似性。详细了解 OT 与受体相互作用的机制很重要,并且可能有助于基于配体或结构设计选择性和有效的配体。在本文中,我们比较了 69 种 OT 和 OT 样受体序列的分子进化和多样性,利用计算机模拟方法将最近发表的 G 蛋白偶联受体结构的常见配体相互作用位点映射到人类 OTR(OT 受体)模型上,并在一系列不同的 OTR 序列中比较了这些相互作用的残基。我们的分析表明,在受体的共同跨膜核心区域内存在 OT 肽的结合位点,但似乎极难确定能够解释 OT 对其受体的选择性的受体或配体残基。我们仍然相信,所呈现的进化概述和建模方法将有助于解释即将到来的 OTR 晶体结构。